LINDSEY POLCARI: Open Payments
NPI 1710659230 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 55 payments from 27 companies in 2025. Trend: 2023 $584 · 2024 $250 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $190 |
| Janssen Biotech, Inc. | 10 | $162 |
| AstraZeneca Pharmaceuticals LP | 5 | $146 |
| Incyte Corporation | 4 | $98 |
| Tempus AI, Inc | 2 | $60 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| SOBI, INC | 2 | $48 |
| PFIZER INC. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Blue Earth Diagnostics | 1 | $35 |
Products named: SCEMBLIX, JAKAFI, Fabhalta, XT CDX, ERLEADA, DARZALEX, Vonjo, LYNPARZA.
Industry payments across AZ — which companies pay providers there.
